{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:25:48Z","timestamp":1769311548441,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10072-022-06055-2","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T18:03:51Z","timestamp":1649354631000},"page":"3979-3982","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Expanding the spectrum of SOX1-antibodies in neuropathy: the coexistence of anti-SOX1 and Guillain-Barr\u00e9 syndrome\u2014a case report"],"prefix":"10.1007","volume":"43","author":[{"given":"S.","family":"Coniglio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Turchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mazzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Meletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6280-7526","authenticated-orcid":false,"given":"Anna Elisabetta","family":"Vaudano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"6055_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, Van Den Berg B, Drenthen J, Walgaard C, Van Doorn PA, Jacobs BC (2014) Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain 137:33\u201343. https:\/\/doi.org\/10.1093\/brain\/awt285","journal-title":"Brain"},{"key":"6055_CR2","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt P, SillevisYedeler Ch, Verschuuren JJGM, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135\u20131140. https:\/\/doi.org\/10.1136\/jnnp.2003.034447","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6055_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.03.020","volume":"165","author":"F Graus","year":"2005","unstructured":"Graus F, Vincent A, Pozo-Rosich P, Sabater L, Saiz A, Lang B, Dalmau J (2005) Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes. J Neuroimmunol 165:166\u2013171","journal-title":"J Neuroimmunol"},{"key":"6055_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3988\/jcn.2020.16.4.530","volume":"16","author":"X Sun","year":"2020","unstructured":"Sun X, Tan J, Sun H, Liu Y, Guan W, Jia J, Wang Z (2020) Anti-sox1 antibodies in paraneoplastic neurological syndrome. J Clin Neurol 16:530\u2013546. https:\/\/doi.org\/10.3988\/jcn.2020.16.4.530","journal-title":"J Clin Neurol"},{"key":"6055_CR5","doi-asserted-by":"publisher","first-page":"S1388-2457(22)0","DOI":"10.1016\/j.clinph.2021.12.014","volume":"13","author":"S Arends","year":"2022","unstructured":"Arends S, Drenthen J, van den Bergh P, Franssen H, Hadden RDM, Islam B, Kuwabara S, Reisin RC, Shahrizaila N, Amino H, Antonini G, Attarian S, Balducci C, Barroso F, Bertorini T, Binda D, Brannagan TH, Buermann J, Casasnovas C, Cavaletti G, Chao CC, Dimachkie MM, Fulgenzi EA, Galassi G, Guti\u00e9rrez Guti\u00e9rrez G, Harbo T, Hartung HP, Hsieh ST, Kiers L, Lehmann HC, Manganelli F, Marfia GA, Mataluni G, Pardo J, P\u00e9r\u00e9on Y, Rajabally YA, Santoro L, Sekiguchi Y, Stein B, Stettner M, Uncini A, Verboon C, Verhamme C, Vytopil M, Waheed W, Wang M, Zivkovic S, Jacobs BC, Cornblath DR, IGOS consortium (2022) Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: differences in methods and reference values. Clin Neurophysiol 13:S1388-2457(22)00011\u20136. https:\/\/doi.org\/10.1016\/j.clinph.2021.12.014","journal-title":"Clin Neurophysiol"},{"key":"6055_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","volume":"86","author":"YA Rajabally","year":"2015","unstructured":"Rajabally YA, Durand MC, Mitchell J, Orlikowski D, Nicolas G (2015) Electrophysiological diagnosis of Guillain-Barr\u00e9 syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry 86:115\u20139. https:\/\/doi.org\/10.1136\/jnnp-2014-307815","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6055_CR7","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1016\/j.clinph.2018.09.025","volume":"129","author":"A Uncini","year":"2018","unstructured":"Uncini A, Kuwabara S (2018) The electrodiagnosis of Guillain-Barr\u00e9 syndrome subtypes: where do we stand? Clin Neurophysiol 129:2586\u20132593. https:\/\/doi.org\/10.1016\/j.clinph.2018.09.025","journal-title":"Clin Neurophysiol"},{"key":"6055_CR8","doi-asserted-by":"publisher","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, Antoine JCG, Desestret V, Dubey D et al (2021) Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflammation 8. https:\/\/doi.org\/10.1212\/NXI.0000000000001014","DOI":"10.1212\/NXI.0000000000001014"},{"key":"6055_CR9","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","volume":"70","author":"L Sabater","year":"2008","unstructured":"Sabater L, Titulaer M, Saiz A, Verschuuren J, G\u00fcre AO, Graus F (2008) SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 70:924\u2013928. https:\/\/doi.org\/10.1212\/01.wnl.0000281663.81079.24","journal-title":"Neurology"},{"key":"6055_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jns.2016.09.002","volume":"369","author":"B Berger","year":"2016","unstructured":"Berger B, Dersch R, Ruthardt E, Rasiah C, Rauer S, Stich O (2016) Prevalence of anti-SOX1 reactivity in various neurological disorders. J Neurol Sci 369:342\u2013346. https:\/\/doi.org\/10.1016\/j.jns.2016.09.002","journal-title":"J Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06055-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06055-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06055-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T03:50:05Z","timestamp":1653018605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06055-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6055"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06055-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"assertion":[{"value":"19 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have received patient consent form for data collection and publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We obtained the patients\u2019 consent for data collection and publication. All procedures performed were in accordance\u00a0with the ethical standards of the Area Vasta Emila Nord (AVEN) local ethical committee and with the 1964 Helsinki\u00a0Declaration and its later amendments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}